Monday, January 18, 2021 Daily Archives

CDMO round-up: News from Baxter, AMRI, Lonza and Fujifilm

by

Baxter announces agreement with Novavax; BARDA adds AMRI facility; Lonza collaborates with Capricor to develop candidate; Fujifilm will help to manufacture Novavax’s COVID-19 candidate. Great to have you here for Bioprocess Insider’s CDMO round-up. First up in our contract development manufacturing organization (CDMO) round-up is Baxter BioPharma Solutions, which recently  confirmed a sterile manufacturing agreement for Novavax COVID-19 vaccine, NVX-CoV2373. “Baxter’s sterile manufacturing services will take place at our facility located in Halle/Westfalen, Germany using existing manufacturing capacity. The facility has…

January 18, 2021

Joint venture promises to reduce manufacturing cost of cell and gene

by

Three organizations have created ScaleReady to provide a ‘cost-effective’ cell and gene production platform. The joint venture combines the capabilities of Bio-Techne, Fresenius Kabi, and Wilson Wolf, which each take an equal share in the newly created business. ScaleReady will offer technologies for cell culture, cell activation, gene editing and cell processing developed separately by these companies. The joint venture business itself will provide the sales, marketing, and application support for the cell and gene therapy manufacturing platform created by…

January 18, 2021